Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001437749-22-003021

Pres. Diagnostics & Genom acquired 1,989 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2022-02-08 Option exercise +1,989 $150.78 $299,901 1,989 D
Derivatives
Kelderman Kim Pres. Diagnostics & Genom 2022-02-08 Option exercise · Stock Option (Right to Buy) −1,989 7,511 D
Loading xslF345X03/rdgdoc.xml…